Non-surgical management of stage 3 biphosphonate-related oroantral fistula.
We describe the case of a patient with an oroantral fistula that healed successfully after conservative treatment.
Hindawi
Mohammad
M
Maxillofacial Unit, Central Outpatients, University Hospital of North Staffordshire, Hartshill Road, Stoke On Trent ST4 7PA, United Kingdom. hindawi1974@yahoo.com
Bainton
Roger
R
Srinivasan
Dillip
D
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002981:Clindamycin / Q000627:therapeutic use; D004002:Clodronic Acid / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006861:Hydrogen Peroxide / Q000627:therapeutic use; D000077557:Ibandronic Acid; D008439:Maxillary Diseases / Q000139:chemically induced; D008875:Middle Aged; D009957:Oroantral Fistula / Q000139:chemically induced / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced; D011206:Povidone-Iodine / Q000627:therapeutic use; D014081:Tooth Extraction
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004002:Clodronic Acid; D002981:Clindamycin; D011206:Povidone-Iodine; D006861:Hydrogen Peroxide; D000077557:Ibandronic Acid